Content Engine
The high-leverage assets that move pharma BD teams to email you, that investors quote in committee meetings, that journalists actually open. Whitepapers, technical case studies, scientific blog posts — all written by people who understand your science.
- Technical whitepapers (10–20 pages, peer-review quality)
- Scientific case studies and clinical narrative pieces
- Long-form thought leadership for industry publications
- Founder-perspective op-eds for placement in Endpoints, Fierce, BioSpace
- Interview-driven articles featuring your KOLs